Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-149-1 | CAS number: 103-83-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Remarks:
- Communication number: CCH-D-2114504234-63-01/D_Additional information included.
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No OECD Guideline defined.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
- Reference Type:
- secondary source
- Title:
- Dimethylbenzylamine - Micronucleus test in bone marrow cells of the mouse
- Author:
- Völkner W.
- Year:
- 1 987
- Bibliographic source:
- LMP 262 (1987)||cited in:|Heiman H-G, Huber W|Mutagenitätsprüfungen von Arbeitsstoffen mit wesentlicher Bedeutung und Verbreitung|GUM, 4/89: 2-6 (1989)
- Reference Type:
- publication
- Title:
- Mutagenitätsprüfungen von Arbeitsstoffen mit wesentlicher Bedeutung und Verbreitung
- Author:
- Heimann K.-G- et al.
- Year:
- 1 998
- Bibliographic source:
- GUM 4/89
Materials and methods
- Principles of method if other than guideline:
- The test substance was assessed for mutagenic properties in the micronucleus test with bone marrow cells of the mouse. The dosing was 15, 50, 150 mg/kg bw. (24 h); 150 mg/kg bw (48h); 150 mg/kg bw (72 h). The administration was per os (stomach tube); single. Preparation of the bone marrow cells was done 24, 48 and 72 h after the administration of the test substance.
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Benzyldimethylamine
- EC Number:
- 203-149-1
- EC Name:
- Benzyldimethylamine
- Cas Number:
- 103-83-3
- Molecular formula:
- C9H13N
- IUPAC Name:
- benzyldimethylamine
- Details on test material:
- TS-Freetext:
Purity: 99.34 %
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 2.5-4 months
- Housing: individually
- Diet ad libitum
- Water ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21
- Humidity (%): 40-60
- Air changes (per hr):10
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- DMSO
- Details on exposure:
- Single oral administration of the test substance diluted in DMSO by gavage.
- Duration of treatment / exposure:
- single administration
- Frequency of treatment:
- single administration
- Post exposure period:
- 24, 48, 72 hours, respectively
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 15, 50, 150 mg/kg bw
Basis:
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Positive control(s):
- cyclophosphamide
Examinations
- Tissues and cell types examined:
- mouse bone marrow cells
- Details of tissue and slide preparation:
- The animals were killed by cervical dislocation. The femora were removed and freed from muscles and tissue. The epiphyses were cut off with scissors and the marrow was fluxhed out with fetal calf serum. The cell suspension was centrifuged and the pellet spread on a slide . The smear was air-dryed and then stained with May-Grünwald/Giemsa. Cover slips were mounted with Eukitt. 3 Slides were made from each animal.
- Evaluation criteria:
- no data
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- 150 mg/kg bw: reduction of spontaneous activity and reduced food and water consumption in a pre-test.
- Vehicle controls validity:
- not specified
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Toxicity:
150 mg/kg produced reduction of spontaneous activity and reduced food and water consumption in a pre-test.
Any other information on results incl. tables
Result of the dose range finding “pre-experiment” as indicated in the study report:
Dosing was chosen with regard to the results of a pre-experiment. 150 mg/kg b.w. of the test substance was the highest non-lethal dose. With this dose the animals expressed the following toxic reactions but no mortality: reduction of spontaneous activity, no food and water uptake for 1 hour after administration.
With higher doses of the test substance animals died in the dose range finding “pre-experiment”. The following results were reported:
200 mg/kg b.w. dosing: 1 out of 6 treated animals died.
250 mg/kg b.w. dosing: 1 out of 6 treated animals died.
300 mg/kg b.w. dosing: 3 out of 6 treated animals died.
Main study:
Therefore the following doses in the main study were used:
Group | Substance | Dose [mg/kg b.w. |
Preparation hours p. admin. |
Number of animals analyses Males : females = 5 : 5 per group |
1 |
solvent |
0 |
24 |
10 |
2 |
solvent |
0 |
48 |
10 |
3 |
solvent |
0 |
72 |
10 |
4 |
CPA |
30 |
24 |
10 |
5 |
test substance |
15 |
24 |
10 |
6 |
test substance |
50 |
24 |
10 |
7 |
test substance |
150 |
24 |
10 |
8 |
test substance |
150 |
48 |
10 |
9 |
test substance |
150 |
72 |
10 |
CPA = Cyclophosphamide
The requirements specified in the OECD guideline no. 474 are as follows:
“If a preliminary range-finding study is performed because there are no suitable data already available to aid in dose selection, it should be performed in the same laboratory, using the same species, strain, sex, and treatment regimen to be used in the main study. The study should aim to identify the maximum tolerated dose (MTD), defined as the highest dose that will be tolerated without evidence of study-limiting toxicity, relative to the duration of the study period (for example, by inducing body weight depression or hematopoietic system cytotoxicity, but not death or evidence of pain, suffering or distress necessitating humane euthanasia)” are fulfilled.
Based on the data of the dose range finding “pre-experiment” the selected dose of 150 mg/kg is considered appropriate according to the OECD TG 474.
In addition, reduction in the proportion of immature erythrocytes among total erythrocytes in the bone marrow might be considered to conclude if a compound reached the target tissue. Within the main study the relationship PE/NE (polychromatic erythrocytes (PE) / normochromatic (NE) was examined.
It is considered that a decrease of the ratio of polychromatic erythrocytes to normochromatic erythrocytes (PE/NE) in the micronucleus test is an indicator to conclude if a compound reached the target tissue.
Group | Substance | Dose [mg/kg b.w.] |
Preparation hours p. admin. |
Polychromatic Erytrocytes with micronulei |
Range |
PE/NE |
1 |
solvent |
0 |
24 |
0.14% |
0 - 5 |
1000/455 |
2 |
solvent |
0 |
48 |
0.06% |
0 - 3 |
1000/885 |
3 |
solvent |
0 |
72 |
0.09% |
0 - 2 |
1000/435 |
4 |
CPA |
30 |
24 |
1.22% |
4 - 24 |
1000/644 |
5 |
test substance |
15 |
24 |
0.15% |
0 - 4 |
1000/498 |
6 |
test substance |
50 |
24 |
0.18% |
0 - 4 |
1000/516 |
7 |
test substance |
150 |
24 |
0.13% |
0 - 2 |
1000/441 |
8 |
test substance |
150 |
48 |
0.10% |
0 - 2 |
1000/702 |
9 |
test substance |
150 |
72 |
0.10% |
0 - 3 |
1000/442 |
The effects of a decrease of the ratio of PE/NE (polychromatic erythrocytes / normochromatic erythrocytes in the highest dose applied (150 mg/kg b.w.) is not evident compared to the solvent at 24 and 72 hours after administration of the test substance, however a clear effect exists at 48 hours.
The mean value of the solvent is 592 (at 24, 48 and 72 h NE is (455 + 885 + 435) : 3) whereas the mean value of the test substance at 150 mg/kg bw is 528 (at 24, 48 and 72 h NE is (441 + 702 + 442) : 3).
This means, the ratio of polychromatic erythrocytes to normochromatic erythrocytes = (PE/NE) decreased from 592 to 528.
Conclusion:
In a range finding “pre-experiment” the maximum non-lethal tolerated dose (MTD) was 150 mg/kg b.w. At higher doses (200 mg/kg b.w. and above) mortality was observed. Consequently the selected high dose of 150 mg/kg b.w. in the main experiment is considered appropriate according to the OECD TG 474 and the negative result in this guideline study is considered valid.
Applicant's summary and conclusion
- Conclusions:
- The test substance did not show any mutagenic activity as determined by the micronucleus test with mouse bone marrow cells .
- Executive summary:
The test substance was assessed for mutagenic activity in the micronucleus test in vivo with bone marrow cells of the mouse.
Male and female mice were given single oral doses by gavage 0, 15, 50, 150 mg/kg bw. (24 h); 150 mg/kg bw (48h); 150 mg/kg bw (72 h).diluted in DMSO. Toxicity was examined in a pre-experiment. 150 mg/kg bw was the highest non-lethal dose but animals showed reduction of spontaneous activity and no food and water uptake was observed for up to 1 hour post application in that test..
Preparation of mice bone marrow cells was done 24, 48 and 72 h after the administration of the test substance.
With no dose at no preparation time any enhanced micronucleus rates were found. The sensitivity of the test system was shown by administration of cyclophosphamide (positive control) which induced a significantly higher micronucleus rate as compared to the negative controls.
The test substance did not show any mutagenic activity as determined by the micronucleus test with bone marrow cells.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
